Clinical trials · Denver, CO
Diabetes clinical trials in Denver
We’re tracking 72 recruiting diabetes studies with a site in or near Denver — including Early Phase 1, Phase 1, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Denver
- NCT07494188Enrolling by invitation
Sleep screening for teens with type 1 diabetes
This study screens teenagers with type 1 diabetes for sleep problems and offers support to improve sleep, which may help with blood sugar control.
Aurora, ColoradoAges 11–17 - NCT06618027Recruiting
Mindfulness program for teens with type 1 diabetes and mood concerns
This trial tests a mindfulness program designed to help teens with type 1 diabetes who are also dealing with feelings of depression or anxiety. The goal is to see if this program can improve their mood and overall well-being.
Aurora, ColoradoAges 13–17 - NCT07664553RecruitingPhase 3
Testing a new diabetes tablet for people on insulin
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
Aurora, ColoradoAges 18 years+ - NCT07579702Recruiting
Omnipod 6 Versus Omnipod 5 Insulin Pump System
This study compares two versions of the Omnipod insulin pump system to see if the newer Omnipod 6 works better at managing blood sugar than the current Omnipod 5. You'll wear one of these systems for several months and share data about how well it helps control your diabetes.
Aurora, ColoradoAges 14–75 - NCT06217302RecruitingPhase 3
Sotagliflozin for kidney protection in type 1 diabetes
This study tests whether sotagliflozin (a pill that helps control blood sugar and protects the kidneys) can slow down kidney function decline in people with type 1 diabetes and diabetic kidney disease. You may qualify if you have had type 1 diabetes for at least 8 years, have moderate kidney damage, and are on standard treatments.
Aurora, ColoradoAges 18–75 - NCT06141434Recruiting
Maternal Exposures and Baby Diabetes Risk Study
This study follows pregnant women and their babies to learn how early-life factors may affect the risk of type 1 diabetes. If your baby has a parent or sibling with type 1 diabetes, you may be able to join.
Aurora, ColoradoAges birth–99 years - NCT06140537RecruitingPhase 4
Dapagliflozin for kidney and heart health after transplant
This study tests whether a diabetes drug called dapagliflozin (Farxiga) can help protect your kidney function and heart health after a kidney transplant. It's for people who have had a transplant for at least a year and have diabetes or post-transplant diabetes.
Aurora, ColoradoAges 18–80 - NCT07409714RecruitingEarly Phase 1
Montelukast for kidney and heart health in young adults with type 2 diabetes
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
Aurora, ColoradoAges 14–24 - NCT07011147Recruiting
Real-world test of automated insulin delivery in primary care
This study tests if an automated insulin delivery system (the iLet bionic pancreas) works well in real-world primary care settings for people with type 1 or type 2 diabetes. It aims to see if this technology can help manage blood sugar more easily.
Aurora, ColoradoAges 18–89 - NCT06191094Enrolling by invitationPhase 4
Vabysmo before eye surgery for bleeding in diabetes
This trial tests if an injection of Vabysmo (faricimab) given before surgery can help people with eye bleeding from diabetic retinopathy. It aims to reduce blood in the eye and improve surgery outcomes.
Aurora, ColoradoAges 18 years+ - NCT07440316Recruiting
Colorado community health study for diverse groups
This study aims to work with Black, East African, Latino, Hispanic, or Native American communities in specific Colorado regions to improve health. It may help you by focusing on the unique needs of your community.
Aurora, ColoradoAges 18–90 - NCT06368817RecruitingPhase 2
Lower radiation dose for children with CNS germinoma
This trial will see if giving a lower dose of radiation therapy can still effectively treat children and young adults with a type of brain tumor called germinoma. The goal is to reduce side effects while keeping the cancer under control.
Aurora, ColoradoAges 3–29 - NCT02915198RecruitingPhase 4
Metformin for prediabetes to reduce heart and blood-vessel events
This trial tests whether taking metformin in people with prediabetes can lower the chance of future heart attack, stroke, or other blood-vessel problems. You may be a good fit if you have prediabetes plus existing cardiovascular disease or significant blood-vessel disease.
Aurora, ColoradoAges 18 years+ - NCT05041491RecruitingEarly Phase 1
Breaking up sitting time to improve blood sugar
This study tests whether changing how often you sit (adding movement breaks) can improve blood sugar control in people at risk for type 2 diabetes. It compares two activity patterns and uses monitoring and brief hospital-style visits with controlled food.
Aurora, ColoradoAges 18–64 - NCT06525259Recruiting
Study on risk factors for type 2 diabetes in youth
This study looks for children and teens who are at high risk of developing type 2 diabetes to understand what factors lead to it. If your child is overweight, has slightly high blood sugar, and is in early to mid-puberty, they may be able to join.
Aurora, ColoradoAges 8–15 - NCT05065372RecruitingPhase 1
Metformin test with automated insulin in teens with type 1
This Phase 1 study tests how adding metformin affects blood flow in the kidneys, insulin sensitivity, and overall heart/metabolic health in young people with type 1 diabetes. It may help researchers understand whether this combo is safe and beneficial alongside automated or pump/shot insulin care.
Aurora, ColoradoAges 12–25 - NCT02734277Recruiting
Extending a past Type 1 diabetes immune study
This study is for people who already took part in an earlier immune-tolerance program for Type 1 diabetes. It tests whether continuing follow-up and assessments can be done safely and may help learn more about long-term immune effects of treatment.
Aurora, ColoradoAges 8–35 - NCT05704309Enrolling by invitation
Study of diabetes prevention participants using brain scans
This study looks at how people who previously took part in a diabetes prevention program are doing over time, including brain health using MRI scans for some participants. It may help researchers understand who is at higher risk for memory and thinking problems and why.
Aurora, ColoradoAges Any age - NCT06455319RecruitingPhase 2
Personalized ATG with or without verapamil for new type 1 diabetes
This trial tests a new way to give a medicine called anti-thymocyte globulin (ATG) with or without verapamil, a blood pressure drug. It aims to slow down the loss of insulin-making cells in people newly diagnosed with type 1 diabetes.
Aurora, ColoradoAges 6–35 - NCT06964087RecruitingPhase 2
Testing OPT101 for type 1 diabetes
This trial tests an investigational drug called OPT101 in people with type 1 diabetes. It aims to see how the drug works in the body and whether it can help preserve insulin production, especially in those diagnosed recently or within the last 20 years.
Aurora, ColoradoAges 18–50 - NCT05482321Recruiting
Pancreas ultrasound imaging study in type 1 diabetes
This study checks whether a special ultrasound scan can clearly picture the pancreas in people with type 1 diabetes and in non-diabetes control participants. It may help researchers better understand the pancreas in diabetes.
Aurora, ColoradoAges 18–65 - NCT05498116RecruitingPhase 4
Montelukast to improve kidney and blood vessel function in type 1 diabetes
This trial tests whether montelukast, a medicine commonly used for allergies, can improve kidney health and blood vessel function in adults with long-term type 1 diabetes. You may join a treatment group and have kidney and circulation measurements taken over the study period.
Aurora, ColoradoAges 18–80 - NCT05543083Recruiting
Therapy plus exercise for teens at risk of type 2 diabetes
This trial tests whether a combination of coaching (cognitive-behavioral therapy) and exercise can improve mood and help teens who are at higher risk for type 2 diabetes. It may be especially helpful if you’re dealing with depression symptoms and a family history of type 2 diabetes.
Aurora, ColoradoAges 12–17 - NCT05544266Recruiting
Study rare diabetes patterns to better guide diagnosis
This study looks at people who may have a “non-typical” form of diabetes, including rare genetic causes or unusual symptoms. It may help your care team understand what type of diabetes you have and whether specific genetic testing could explain it.
Aurora, ColoradoAges Any age
Hear when a new Diabetes trial opens near Denver, CO
We’ll email you when one opens near Denver, CO — at most once a week, no account needed, unsubscribe anytime.
Diabetes trials in other cities
Where these studies are running near Denver
Institutions with a site for the recruiting diabetes studies listed above.
- University of Colorado Anschutz Medical Campus · 5 studies
- University of Colorado · 4 studies
- Children's Hospital Colorado · 3 studies
- Barbara Davis Center
- Barbara Davis Center - University of Colorado Anschuttz Medical Campus
- Barbara Davis Center / University of Colorado Denver
- Barbara Davis Center for Diabetes
- Children's Hospital Colorado/University of Colorado Anschutz Medical Campus
What taking part in a diabetes study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting diabetes studies in Colorado.
Common questions
- Are there diabetes clinical trials near Denver?
- Yes. We're currently tracking 72 recruiting diabetes studies with a site near Denver, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a diabetes study near Denver?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Denver to take part?
- Not necessarily. These studies have a site near Denver, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New diabetes studies open near Denver regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.